Biomelisa is a company operating in the biotechnology and healthcare industry, specializing in the development and production of diagnostic solutions. The company focuses on providing accurate and reliable testing services and products intended for medical laboratories, healthcare providers, and research institutions. Its offerings support the detection and monitoring of various health conditions, contributing to improved clinical decision-making. Biomelisa aims to advance laboratory diagnostics through innovation in biomolecular technologies. The company’s activities encompass research, development, and distribution within the life sciences sector.